共 168 条
[1]
Gill S(2004)Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 22 1797-1806
[2]
Loprinzi CL(1999)Comparative efficacy of adjuvant chemotherapy in patients with Dukes’ B versus Dukes’ C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol. 17 1349-1355
[3]
Sargent DJ(1999)Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer J Clin Oncol. 17 1356-63
[4]
Mamounas E(2000)The hallmarks of cancer Cell. 100 57-70
[5]
Wieand S(2004)Tissue microarrays Biotechniques. 36 98-105
[6]
Wolmark N(1999)Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach J Clin Pathol. 52 283-290
[7]
Hanahan D(1999)Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration–approved scoring system J Clin Oncol. 17 1983-1987
[8]
Weinberg RA(2007)Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer J Clin Pathol. 60 1112-1116
[9]
Simon R(1999)Comparative genomic hybridisation Mol Pathol. 52 243-251
[10]
Mirlacher M(1992)Cancer: p53, guardian of the genome Nature. 358 15-16